Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Clin Infect Dis. 2010 May 15;50(10):1415-8. doi: 10.1086/652150.
Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus-infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%, and 100%, respectively, 1 month after revaccination.
在 38 名接受抗逆转录病毒治疗后免疫功能恢复的人类免疫缺陷病毒感染儿童中,进行麻疹、腮腺炎和风疹的复种 3 年后,麻疹、腮腺炎和风疹保护性抗体水平的流行率分别为 85%、61%和 79%,而在复种后 1 个月,这一比例分别为 88%、84%和 100%。